My research focus is centered on the design of novel strategies to improve patients suffering from thrombotic disorders. My three areas of interest are in the utility of inhibitors of the contact activation pathway of blood coagulation to prevent medical device-related thrombosis, the prevention of blood clotting in patients with sepsis, and the resolution and prevention of post thrombotic syndrome.